← Evidence map

ArticleCureus2025

Atezolizumab-Induced Thyroiditis and Immune Checkpoint Inhibitor (ICI)-Type 1 Diabetes Mellitus: Diagnostic and Therapeutic Challenges in ICI-Associated Endocrinopathies.

Rafal Al-Rubaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Atezolizumab-Induced Thyroiditis and Immune Checkpoint Inhibitor (ICI)-Type 1 Diabetes Mellitus: Diagnostic and Therapeutic Challenges in ICI-Associated Endocrinopathies. | Socratic